Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats.
OBJECTIVE
Sigma receptors are implicated in memory and cognitive functions, drug addiction, depression and schizophrenia. In addition, sigma receptors are strongly overexpressed in many tumours. Although the natural ligands are still unknown, steroid hormones are potential candidates. Here, we examined changes in binding of the sigma-1 agonist (11)C-SA4503 in C6 glioma cells and in living rats after modification of endogenous steroid levels.


METHODS
(11)C-SA4503 binding was assessed in C6 monolayers by gamma counting and in anaesthetized rats by microPET scanning. C6 cells were either repeatedly washed and incubated in steroid-free medium or exposed to five kinds of exogenous steroids (1 h or 5 min before tracer addition, respectively). Tumour-bearing male rats were repeatedly treated with pentobarbital (a condition known to result in reduction of endogenous steroid levels) or injected with progesterone.


RESULTS
Binding of (11)C-SA4503 to C6 cells was increased (approximately 50%) upon removal and decreased (approximately 60%) upon addition of steroid hormones (rank order of potency: progesterone > allopregnanolone = testosterone = androstanolone > dehydroepiandrosterone-3-sulphate, IC(50) progesterone 33 nM). Intraperitoneally administered progesterone reduced tumour uptake and tumour-to-muscle contrast (36%). Repeated treatment of animals with pentobarbital increased the PET standardized uptake value of (11)C-SA4503 in tumour (16%) and brain (27%), whereas the kinetics of blood pool radioactivity was unaffected.


CONCLUSIONS
The binding of (11)C-SA4503 is sensitive to steroid competition. Since not only increases but also decreases of steroid levels affect ligand binding, a considerable fraction of the sigma-1 receptor population in cultured tumour cells or tumour-bearing animals is normally occupied by endogenous steroids.
Rybczynska
Anna A
AA
Nuclear Medicine and Molecular Imaging, University of Groningen Medical Center, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. a.rybczynska@ngmb.umcg.nl
Elsinga
Philip H
PH
Sijbesma
Jurgen W
JW
Ishiwata
Kiichi
K
de Jong
Johan R
JR
de Vries
Erik F
EF
Dierckx
Rudi A
RA
van Waarde
Aren
A
D000818:Animals; D001667:Binding, Competitive; D045744:Cell Line, Tumor; D004195:Disease Models, Animal; D006728:Hormones / Q000378:metabolism*; D008024:Ligands; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology*; D010879:Piperazines / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology; D049268:Positron-Emission Tomography; D051381:Rats; D017480:Receptors, sigma / Q000819:agonists / Q000378:metabolism*; D013256:Steroids / Q000378:metabolism*; D014018:Tissue Distribution
D006728:Hormones; D008024:Ligands; D010879:Piperazines; D017480:Receptors, sigma; D013256:Steroids; C101789:SA 4503